0001209191-19-043260.txt : 20190725
0001209191-19-043260.hdr.sgml : 20190725
20190725185030
ACCESSION NUMBER: 0001209191-19-043260
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190723
FILED AS OF DATE: 20190725
DATE AS OF CHANGE: 20190725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUNST ROBERT A
CENTRAL INDEX KEY: 0001247930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27598
FILM NUMBER: 19975608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRIDEX CORP
CENTRAL INDEX KEY: 0001006045
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 770210467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 1212 TERRA BELLA AVE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 6509404700
MAIL ADDRESS:
STREET 1: 1212 TERRA BELLA AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-23
0
0001006045
IRIDEX CORP
IRIX
0001247930
GUNST ROBERT A
1212 TERRA BELLA AVENUE
MOUNTAIN VIEW
CA
94043
1
0
0
0
Common Stock
2019-07-23
4
A
0
11204
0.00
A
23304
D
Stock Option (right to buy)
3.57
2019-07-23
4
A
0
15000
0.00
A
2026-07-23
Common Stock
15000
15000
D
Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders.
This option granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule16b-3.
The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest on August 23, 2019 and each month thereafter.
/s/ Nilo De Castro, Attorney-in-Fact for Robert A. Gunst
2019-07-25